drugset / Trial / NCT00030030
Evaluating Silymarin for Chronic Hepatitis C
Phase 2
Completed
National Center for Complementary and Integrative Health (NCCIH)
Office of Dietary Supplements (ODS) · collab
RandomizedDouble-blindPrevention
Summary
To investigate the effect of silymarin, derived from the milk thistle plant, Silybum marianum, in preventing and reversing the complications of chronic infection with hepatitis C virus and/or clearing hepatitis C infections.
Timeline
- Start
- 2000-07
- Primary completion
- —
- Completion
- 2002-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Silymarin | Traditional medicine (herbal / TCM) | — | — |